Unknown

Dataset Information

0

Vaccine adjuvant activity of a TLR4-activating synthetic glycolipid by promoting autophagy.


ABSTRACT: Toll-like receptors (TLRs) play crucial roles in host immune defenses. Recently, TLR-mediated autophagy is reported to promote immune responses via increasing antigen processing and presentation in antigen presenting cells. The present study examined whether the synthetic TLR4 activator (CCL-34) could induce autophagy to promote innate and adaptive immunity. In addition, the potential of CCL-34 as an immune adjuvant in vivo was also investigated. Our data using RAW264.7 cells and bone marrow-derived macrophages showed that CCL-34 induced autophagy through a TLR4-NF-?B pathway. The autophagy-related molecules (Nrf2, p62 and Beclin 1) were activated in RAW264.7 cells and bone marrow-derived macrophages under CCL-34 treatment. CCL-34-stimulated macrophages exhibited significant antigen-processing activity and induced the proliferation of antigen-specific CD4+T cells as well as the production of activated T cell-related cytokines, IL-2 and IFN-?. Furthermore, CCL-34 immunization in mice induced infiltration of monocytes in the peritoneal cavity and elevation of antigen-specific IgG in the serum. CCL-34 treatment in vivo did not cause toxicity based on serum biochemical profiles. Notably, the antigen-specific responses induced by CCL-34 were attenuated by the autophagy inhibitor, 3-methyladenine. In summary, we demonstrated CCL-34 can induce autophagy to promote antigen-specific immune responses and act as an efficient adjuvant.

SUBMITTER: Chou YJ 

PROVIDER: S-EPMC7242473 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vaccine adjuvant activity of a TLR4-activating synthetic glycolipid by promoting autophagy.

Chou Yi-Ju YJ   Lin Ching-Cheng CC   Dzhagalov Ivan I   Chen Nien-Jung NJ   Lin Chao-Hsiung CH   Lin Chun-Cheng CC   Chen Szu-Ting ST   Chen Kuo-Hsin KH   Fu Shu-Ling SL  

Scientific reports 20200521 1


Toll-like receptors (TLRs) play crucial roles in host immune defenses. Recently, TLR-mediated autophagy is reported to promote immune responses via increasing antigen processing and presentation in antigen presenting cells. The present study examined whether the synthetic TLR4 activator (CCL-34) could induce autophagy to promote innate and adaptive immunity. In addition, the potential of CCL-34 as an immune adjuvant in vivo was also investigated. Our data using RAW264.7 cells and bone marrow-der  ...[more]

Similar Datasets

| S-EPMC8054148 | biostudies-literature
| S-EPMC3243550 | biostudies-literature
| S-EPMC3881025 | biostudies-literature
| S-EPMC6830872 | biostudies-literature
| S-EPMC7318308 | biostudies-literature
| S-EPMC3027669 | biostudies-literature
| S-EPMC4695023 | biostudies-literature
| S-EPMC5176129 | biostudies-literature
| S-EPMC6759631 | biostudies-literature